Pacira Biosciences Agreement with Premier Inc

Pacira Biosciences Secures Agreement for Brand Pharmaceuticals with Premier, Inc

Pacira BioSciences, Inc. 

known for its focus on non-opioid pain management and regenerative health solutions, has secured a national group purchasing agreement for Brand Pharmaceuticals with Premier, Inc. This agreement, effective from January 1, 2024, enables Premier members to access special pricing and terms for EXPAREL® (bupivacaine liposome injectable suspension).

The partnership aims to enhance patient care and drive cost efficiencies for healthcare organizations, allowing Premier members to utilize EXPAREL. This innovative single-dose local and regional analgesic offers extended postsurgical pain relief while reducing reliance on opioids.

Pacira BioSciences, expressed enthusiasm about the collaboration, stating, “Premier boasts an extensive network of U.S. hospitals and health systems, presenting Pacira with an exceptional avenue to broaden its reach while elevating patient safety and care. We take pride in partnering with organizations like Premier as we strive to expand access to non-opioid pain management solutions for patients nationwide.”

Aligned in their mission to drive innovation, enhance patient outcomes, and deliver value in healthcare, Pacira and Premier anticipate significant contributions through this collaboration. By uniting approximately 4,350 U.S. hospitals and 300,000 providers, Premier, a leading healthcare improvement company, leverages integrated data, analytics, and various services to facilitate better care and outcomes at reduced costs.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!